Fimepinostat T2078
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
CUDC-907 is an orally bioavailable inhibitor of both phosphoinositide 3-kinase (PI3K) class I and pan-histone deacetylase (HDAC) enzymes, with potential antineoplastic activity. Upon oral administration, CUDC-907 inhibits the activity of both PI3K class I
CAS nr:
1339928-25-4
Purity:
98%
Molecular Weight:
508,55
SMILES:
c1nc(ncc1C(=O)NO)N(C)Cc1cc2c(s1)c(nc(n2)c1ccc(nc1)OC)N1CCOCC1
Formula:
C23H24N8O4S
Pathway:
DNA Damage/DNA Repair,Chromatin/Epigenetic,PI3K/Akt/mTOR signaling,Apoptosis
Target:
HDAC,HDAC,PI3K,Apoptosis
